Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Rausch

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Urologie (Heidelberg, Germany)|December 23, 2025
[Treatment options in rare urological tumors: potential of molecular tumor boards]Steffen Rausch, Isabel Heidegger, Johannes Linxweiler, et al.
Expert Opinion on Biological Therapy|October 8, 2019
Immune checkpoint inhibition for the treatment of renal cell carcinomaViktoria Stühler, Jan Moritz Maas, Steffen Rausch, et al.
Urologia Internationalis|April 18, 2023
Prospective Analysis of Versatility and User Satisfaction with a Novel Single-Use Cystoscope with Working ChannelThomas Lütfrenk, Andreas Neisius, Steffen Rausch, et al.
Expert Opinion on Biological Therapy|May 27, 2021
Pembrolizumab for the treatment of renal cell carcinomaCarlo Di Bona, Viktoria Stühler, Steffen Rausch, et al.
Expert Opinion on Biological Therapy|February 12, 2021
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinomaViktoria Stühler, Steffen Rausch, Jan Moritz Maas, et al.
Urologie (Heidelberg, Germany)|April 2, 2025
[Bispecific antibodies in prostate cancer therapy]Susanne Jung, Jonas Heitmann, Martin Pflügler, et al.
Anticancer Research|December 25, 2016
Laparoscopic versus Open Partial Nephrectomy: Comparison of Overall and Subgroup OutcomesMohamed Abdelhafez, Amend Bastian, Steffen Rausch, et al.
Urologie (Heidelberg, Germany)|August 6, 2024
[Molecular tumor boards in uro-oncology-prostate cancer]Frank Kunath, Isabel Heidegger, Matthias Heck, et al.
Asian Journal of Andrology|August 25, 2017
Circulating tumor cells and their role in prostate cancerMoritz Maas, Miriam Hegemann, Steffen Rausch, et al.
World Journal of Urology|February 27, 2021
The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinomaViktoria Stühler, Steffen Rausch, Katharina Kroll, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Urologie (Heidelberg, Germany)|December 23, 2025
[Treatment options in rare urological tumors: potential of molecular tumor boards]Steffen Rausch, Isabel Heidegger, Johannes Linxweiler, et al.
Expert Opinion on Biological Therapy|October 8, 2019
Immune checkpoint inhibition for the treatment of renal cell carcinomaViktoria Stühler, Jan Moritz Maas, Steffen Rausch, et al.
Urologia Internationalis|April 18, 2023
Prospective Analysis of Versatility and User Satisfaction with a Novel Single-Use Cystoscope with Working ChannelThomas Lütfrenk, Andreas Neisius, Steffen Rausch, et al.
Expert Opinion on Biological Therapy|May 27, 2021
Pembrolizumab for the treatment of renal cell carcinomaCarlo Di Bona, Viktoria Stühler, Steffen Rausch, et al.
Expert Opinion on Biological Therapy|February 12, 2021
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinomaViktoria Stühler, Steffen Rausch, Jan Moritz Maas, et al.
Urologie (Heidelberg, Germany)|April 2, 2025
[Bispecific antibodies in prostate cancer therapy]Susanne Jung, Jonas Heitmann, Martin Pflügler, et al.
Anticancer Research|December 25, 2016
Laparoscopic versus Open Partial Nephrectomy: Comparison of Overall and Subgroup OutcomesMohamed Abdelhafez, Amend Bastian, Steffen Rausch, et al.
Urologie (Heidelberg, Germany)|August 6, 2024
[Molecular tumor boards in uro-oncology-prostate cancer]Frank Kunath, Isabel Heidegger, Matthias Heck, et al.
Asian Journal of Andrology|August 25, 2017
Circulating tumor cells and their role in prostate cancerMoritz Maas, Miriam Hegemann, Steffen Rausch, et al.
World Journal of Urology|February 27, 2021
The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinomaViktoria Stühler, Steffen Rausch, Katharina Kroll, et al.
Pageof 13